Balchem Corporation

Fundamentals8.0
Price Action6.0
News Sentiment5.0
AI Rating
6.0

Key Drivers

  • Margin stability
  • Strong cash flow
  • Low leverage

AI
AI Summary

6.0

BCPC looks like a high-quality specialty ingredient compounder with strong ROIC, cash flow, and balance-sheet resilience, but at roughly 35x earnings and without a new catalyst after the latest miss, the stock's upside now depends on flawless execution and margin stability more than multiple expansion.

Quality
Valuation
Execution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • Margin stability
  • Strong cash flow
  • Low leverage

BCPC has strong margins, healthy cash flow, low leverage, and efficient capital use, but its premium valuation and intangible-heavy asset base leave limited margin for error.

Quality
Premium

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher lows
  • Near highs
  • Cooling momentum

BCPC remains technically constructive over the last month, with higher lows and prices near recent highs, but momentum has cooled and the mid-$160s support is key.

BCPC
Consolidation
Support Level: $165.00–$166.00
Resistance Level: $171.22, then $173.33

Price eased from $169.21 to $168.80, suggesting a mild consolidation near highs

Sentiment & News

5.0

Key News Insights:

  • Investor presentation
  • No outlook change
  • Health nutrition focus

Balchem will present at the CJS Securities Summer Conference on July 9, signaling an investor-relations event with no change to its operating outlook.

InvestorRelations
ConferenceParticipation

This announcement is likely neutral for BCPC, as it mainly reflects routine engagement with investors rather than a material business development